日期 影响因子
日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:
–

Afuresertib plus fulvestrant for pretreated HR-positive, HER2-negative, advanced breast cancer: a phase Ib trial

阿福塞替尼联合氟维司群治疗既往接受过治疗的HR阳性、HER2阴性晚期乳腺癌：一项Ib期试验

期刊:Nature Communications
影响因子:15.7
doi:10.1038/s41467-026-69225-2
Zhang, Pin; Sun, Tao; Wang, Ying; Li, Wei; Tong, Zhongsheng; Phadke, Sneha; Feinstein, Trevor; Ma, Wenyue; Guo, Pengfei; Zhang, Minhua; Yue, Yong; Xu, Binghe
HER2
肿瘤
肿瘤免疫
乳腺癌
发表日期：2026
文献求助 收藏

Trilaciclib prior to chemotherapy reduces the usage of supportive care interventions for chemotherapy-induced myelosuppression in patients with small cell lung cancer: Pooled analysis of three randomized phase 2 trials

在小细胞肺癌患者中，化疗前使用曲拉西利可减少化疗引起的骨髓抑制所需的辅助治疗干预措施：三项随机 II 期试验的汇总分析

期刊:Cancer Medicine
影响因子:3.1
doi:10.1002/cam4.4089
Ferrarotto, Renata; Anderson, Ian; Medgyasszay, Balazs; García-Campelo, Maria Rosario; Edenfield, William; Feinstein, Trevor M; Johnson, Jennifer M; Kalmadi, Sujith; Lammers, Philip E; Sanchez-Hernandez, Alfredo; Pritchett, Yili; Morris, Shannon R; Malik, Rajesh K; Csőszi, Tibor
肺癌
细胞生物学
肿瘤
肿瘤免疫
发表日期：2021
文献求助 收藏

Phase I and pharmacokinetic study of dasatinib and cetuximab in patients with advanced solid malignancies.

达沙替尼和西妥昔单抗治疗晚期实体恶性肿瘤患者的 I 期药代动力学研究

期刊:Investigational New Drugs
影响因子:2.7
doi:10.1007/s10637-011-9732-3
Argiris Athanassios, Feinstein Trevor M, Wang Lin, Yang Tianbing, Agrawal Shruti, Appleman Leonard J, Stoller Ronald G, Grandis Jennifer R, Egloff Ann Marie
肿瘤
发表日期：2012
文献求助 收藏

Serum biomarkers as potential predictors of antitumor activity of cetuximab-containing therapy for locally advanced head and neck cancer.

血清生物标志物作为预测局部晚期头颈癌患者接受含西妥昔单抗治疗的抗肿瘤活性的潜在指标

期刊:Oral Oncology
影响因子:3.9
doi:10.1016/j.oraloncology.2011.07.034
Argiris Athanassios, Lee Steve C, Feinstein Trevor, Thomas Sufi, Branstetter Barton F 4th, Seethala Raja, Wang Lin, Gooding William, Grandis Jennifer R, Ferris Robert L
肿瘤
头颈癌
肿瘤免疫
发表日期：2011
文献求助 收藏

Prognostic factors in patients with high-risk locally advanced salivary gland cancers treated with surgery and postoperative radiotherapy

接受手术和术后放疗的高危局部晚期唾液腺癌患者的预后因素

期刊:Head and Neck-Journal for the Sciences and Specialties of the Head and Neck
影响因子:2.2
doi:10.1002/hed.21444
Feinstein, Trevor M; Lai, Stephen Y; Lenzner, Diana; Gooding, William; Ferris, Robert L; Grandis, Jennifer R; Myers, Eugene N; Johnson, Jonas T; Heron, Dwight E; Argiris, Athanassios
肿瘤
肿瘤免疫
发表日期：2011
文献求助 收藏